Skip to content
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Pediatric Endocrinology

The Road Ahead: Long-Term Monitoring and Growth

At a Glance

Pituitary stalk interruption syndrome can cause new hormone deficiencies as a child grows, even when early tests are normal. Lifelong follow-up tracks growth, thyroid and adrenal function, puberty, fertility, and the transition to adult care.

Managing Pituitary Stalk Interruption Syndrome (PSIS) is not a sprint; it is a lifelong journey. Because the pituitary gland’s function can change as your child grows, the most important part of long-term care is consistent monitoring. While the “bridge” in the brain remains interrupted, the way your child’s body responds to that interruption can evolve over many years [1][2].

An “Evolving” Diagnosis

One of the most important things for parents to understand is that the clinical hormone deficiencies of PSIS can accumulate over time. A child who is only missing one hormone at age five may develop a need for others by age fifteen [3].

Research shows that among children who start with Isolated Growth Hormone Deficiency (IGHD), a significant number will eventually develop Multiple Pituitary Hormone Deficiencies (MPHD). In one specific cohort followed for about six years, 47% of children with an initially single deficiency developed additional ones [3]. Other cohort studies have found that as many as 77% of children who lacked only growth hormone eventually required help with puberty hormones as they got older [4]. (These figures reflect specific cohorts; individual risk depends heavily on anatomy, age, and follow-up duration).

Because of this, doctors recommend lifelong surveillance. A “normal” result on a cortisol or thyroid test today is excellent news, but it does not mean that axis will never need support in the future [1][5].

The Surveillance Schedule

To stay ahead of these changes, your child will likely see their pediatric endocrinologist every 6 to 12 months, though visits may be more frequent during infancy or when starting a new medication [1][6].

A standard monitoring visit typically includes:

  • Growth Tracking: Precise measurements of height and weight to calculate growth velocity (how fast your child is growing per year) [7][8].
  • Blood Work: Checking levels of IGF-1 (to monitor growth hormone), Free T4 (for thyroid), and Cortisol (for the adrenal axis) [9][5]. Note: Routine morning cortisol measurement may be uninterpretable or unsafe to arrange for a child already taking hydrocortisone; adrenal monitoring must follow your clinician’s specific plan.
  • Pubertal Staging: As your child enters their pre-teen years, the doctor will check for the first physical signs of puberty [4].
  • Bone Age X-rays: Occasionally, doctors will take an X-ray of the hand and wrist to see how “mature” the bones are, which helps predict how much growth potential remains [7][10].

Navigating Puberty and Fertility

For many children with PSIS, the pituitary signals that trigger puberty are weak or missing (hypogonadotropic hypogonadism). This means your child may need medical assistance to start or complete puberty [4][11].

  • Puberty Induction: If puberty does not start on its own, doctors can use low doses of testosterone (for boys) or estrogen (for girls) to mimic a natural puberty. This supports not only physical development but also bone health and emotional well-being [7][12].
  • Fertility in Adulthood: While sex steroids (like testosterone or estrogen) help with puberty, different medications (called gonadotropins) are used later in life to support fertility. Fertility may be possible with this specialist treatment; for example, one observational study of selected men with PSIS found that 52% achieved sperm production [13]. Many women have also achieved ovulation and conception with assistance, though live birth outcomes are individualized [14].

The Psychological Journey

Growing up with a chronic condition and daily injections can be challenging for both the child and the parents. It is normal for children to go through phases of “needle fatigue” or to feel different from their peers because of their height or medical needs [15].

  • Support and Resilience: Open communication is key. As your child grows, involve them in their care—letting them help prepare the injection or choose which “axis” to learn about next.
  • Quality of Life: The good news is that with proper hormone replacement, most adults with PSIS report a high quality of life. They pursue higher education, enter the workforce, and lead independent lives [14][16].

Your child’s medical team is not just there to monitor blood levels; they are there to help your child navigate the transition from a kid who needs “growth shots” to an adult who confidently manages their own health. Continued monitoring throughout adulthood ensures that they stay healthy, energized, and protected against risks [2][12].

Common questions in this guide

How often should a child with PSIS see an endocrinologist?
Many children with PSIS have endocrine visits every 6 to 12 months. Visits may be more frequent during infancy or after starting a new medicine, and the schedule should be individualized by the treating clinician.
Can PSIS hormone problems appear after earlier tests were normal?
Yes. A child who initially has only growth hormone deficiency may later develop other pituitary hormone deficiencies, so normal thyroid or cortisol results today do not guarantee that hormone support will never be needed.
What is checked during long-term PSIS follow-up?
Clinicians usually measure height and weight, review yearly growth speed, and check blood tests such as IGF-1 and free T4, with cortisol testing when appropriate. They also assess pubertal development and may use a hand and wrist X-ray to estimate bone maturity and remaining growth potential. Cortisol testing should follow the clinician’s plan, especially if a child takes hydrocortisone.
What happens if puberty does not begin on its own in PSIS?
Weak or missing pituitary signals can delay or prevent puberty in some children with PSIS. A specialist may use gradually increased, low-dose testosterone or estrogen to support physical development, bone health, and emotional well-being.
Can adults with PSIS have biological children?
Fertility may be possible for some adults with PSIS, but it usually requires specialist treatment. Gonadotropin medicines can stimulate sperm production or ovulation, and the chance of success depends on the individual’s health and reproductive factors.
How can parents help a child manage PSIS as they grow up?
Open communication and age-appropriate involvement can make daily injections and medicines easier to manage. Families can gradually teach self-care and plan the move from pediatric to adult endocrinology, while seeking psychological or peer support when needed.

Get notified when new evidence is published on Pituitary stalk interruption syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (16)
  1. 1

    DIAGNOSIS OF ENDOCRINE DISEASE: Pituitary stalk interruption syndrome: etiology and clinical manifestations.

    Vergier J, Castinetti F, Saveanu A, et al.

    European journal of endocrinology 2019; (181(5)):R199-R209.

    PMID: 31480013
  2. 2

    Clinical lessons learned in constitutional hypopituitarism from two decades of experience in a large international cohort.

    Jullien N, Saveanu A, Vergier J, et al.

    Clinical endocrinology 2021; (94(2)):277-289 doi:10.1111/cen.14355.

    PMID: 33098107
  3. 3

    Pituitary Magnetic Resonance Imaging as a Prognostic Factor of Pituitary Insufficiency-The Follow-Up Analysis of a Cohort of Children With Pituitary Stalk Interruption Syndrome.

    Chrzanowska J, Jacków-Nowicka J, Bodetko A, et al.

    Clinical endocrinology 2026; (105(2)):231-236 doi:10.1111/cen.70129.

    PMID: 41844520
  4. 4

    Pituitary stalk interruption syndrome: phenotype, predictors, and pathophysiology of perinatal events.

    Diwaker C, Thadani P, Memon SS, et al.

    Pituitary 2022; (25(4)):645-652 doi:10.1007/s11102-022-01243-x.

    PMID: 35749012
  5. 5

    Progression from isolated growth hormone deficiency to combined pituitary hormone deficiency.

    Cerbone M, Dattani MT

    Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 2017; (37()):19-25 doi:10.1016/j.ghir.2017.10.005.

    PMID: 29107171
  6. 6

    Clinical Presentation of Congenital Hypopituitarism: Lessons From a Large Academic Centre.

    Ladd JM, Pyle-Eilola AL, Mamilly L, et al.

    Clinical endocrinology 2025; (102(6)):649-655 doi:10.1111/cen.15213.

    PMID: 39905798
  7. 7

    Growth and Adult Height during Human Growth Hormone Treatment in Chinese Children with Multiple Pituitary Hormone Deficiency Caused by Pituitary Stalk Interruption Syndrome: A Single Centre Study

    Wang F, Han J, Wang Z, et al.

    Journal of clinical research in pediatric endocrinology 2020; (12(1)):71-78 doi:10.4274/jcrpe.galenos.2019.2019.0086.

    PMID: 31475508
  8. 8

    Pituitary Stalk Interruption Syndrome from Infancy to Adulthood: Clinical, Hormonal, and Radiological Assessment According to the Initial Presentation.

    Bar C, Zadro C, Diene G, et al.

    PloS one 2015; (10(11)):e0142354 doi:10.1371/journal.pone.0142354.

    PMID: 26562670
  9. 9

    Congenital Hypopituitarism.

    Parks JS

    Clinics in perinatology 2018; (45(1)):75-91 doi:10.1016/j.clp.2017.11.001.

    PMID: 29406008
  10. 10

    Clinical Features of Pituitary Stalk Interruption Syndrome in 114 Cases.

    Han BY, Zhang Q, Li LL, et al.

    Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae 2016; (38(5)):534-538 doi:10.3881/j.issn.1000-503X.2016.05.007.

    PMID: 27825409
  11. 11

    Puberty and Inhibin B in 35 Adolescents With Pituitary Stalk Interruption Syndrome.

    Corvest V, Lemaire P, Brailly-Tabard S, Brauner R

    Frontiers in pediatrics 2020; (8()):304 doi:10.3389/fped.2020.00304.

    PMID: 32596193
  12. 12

    Bone Mineral Density in Pituitary Stalk Interruption Syndrome: The Role of Insulin-Like Growth Factor-1 and Testosterone at Different Skeletal Sites.

    Zhu Y, Nie M, Wang X, et al.

    Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2022; (28(11)):1118-1124 doi:10.1016/j.eprac.2022.07.011.

    PMID: 35940470
  13. 13

    Efficacy of Pulsatile Gonadotropin-Releasing Hormone Therapy in Male Patients: Comparison between Pituitary Stalk Interruption Syndrome and Congenital Hypogonadotropic Hypogonadism.

    Huang Q, Mao J, Wang X, et al.

    Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2022; (28(5)):521-527 doi:10.1016/j.eprac.2022.02.008.

    PMID: 35218954
  14. 14

    Gonadotropic status in adult women with pituitary stalk interruption syndrome.

    Terray A, Baussart B, Zins M, et al.

    European journal of endocrinology 2024; (190(6)):501-508 doi:10.1093/ejendo/lvae064.

    PMID: 38857190
  15. 15

    Phenotypic heterogeneity in pediatric pituitary stalk interruption syndrome: greater disease burden in the metabolic-onset phenotype.

    Xu F, Su Y, Zhao C, et al.

    Translational pediatrics 2026; (15(9)):363 doi:10.21037/tp-2026-0681.

    PMID: 42865853
  16. 16

    Delayed Diagnosis of Congenital Combined Pituitary Hormone Deficiency including Severe Growth Hormone Deficiency in Children with Persistent Neonatal Hypoglycemia-Case Reports and Review.

    Smyczyńska J, Pawelak N, Hilczer M, Lewiński A

    International journal of molecular sciences 2022; (23(19)) doi:10.3390/ijms231911069.

    PMID: 36232371

This page explains long-term monitoring, growth, puberty, and fertility considerations in PSIS for informational purposes only and does not constitute medical advice. Your child’s endocrinology team should tailor testing and hormone treatment to their age, anatomy, results, and health needs.